Over the past few decades, a large number of live biotherapeutic products, including next-generation probiotics (NGPs), have been developed for treating various types of human and animal diseases. Meanwhile, a panel of detection systems for live biotherapeutic products have been designed and widely used for measuring the safety, efficacy, and product quality in the pharmaceutical industry.